Cargando…

Adenine base editor–mediated correction of the common and severe IVS1-110 (G>A) β-thalassemia mutation

β-Thalassemia (BT) is one of the most common genetic diseases worldwide and is caused by mutations affecting β-globin production. The only curative treatment is allogenic hematopoietic stem/progenitor cells (HSPCs) transplantation, an approach limited by compatible donor availability and immunologic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hardouin, Giulia, Antoniou, Panagiotis, Martinucci, Pierre, Felix, Tristan, Manceau, Sandra, Joseph, Laure, Masson, Cécile, Scaramuzza, Samantha, Ferrari, Giuliana, Cavazzana, Marina, Miccio, Annarita
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society of Hematology 2023
Materias:	Gene Therapy
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10651780/ https://www.ncbi.nlm.nih.gov/pubmed/36508706 http://dx.doi.org/10.1182/blood.2022016629

Ejemplares similares

Lentiviral vectors containing an enhancer-less ubiquitously acting chromatin opening element (UCOE) provide highly reproducible and stable transgene expression in hematopoietic cells
por: Zhang, Fang, et al.
Publicado: (2007)

Human erythrocytes bind and inactivate type 5 adenovirus by presenting Coxsackie virus-adenovirus receptor and complement receptor 1
por: Carlisle, Robert C., et al.
Publicado: (2009)

AAV-mediated gene transfer in the perinatal period results in expression of FVII at levels that protect against fatal spontaneous hemorrhage
por: Binny, Christopher, et al.
Publicado: (2012)

CRISPR-mediated genotypic and phenotypic correction of a chronic granulomatous disease mutation in human iPS cells
por: Flynn, Rowan, et al.
Publicado: (2015)

Prognostic impact of corticosteroids on efficacy of chimeric antigen receptor T-cell therapy in large B-cell lymphoma
por: Strati, Paolo, et al.
Publicado: (2021)

Pharmacokinetic analysis identifies a factor VIII immunogenicity threshold after AAV gene therapy in hemophilia A mice
por: Lundgren, Taran S., et al.
Publicado: (2022)

Comparative effectiveness of ZUMA-5 (axi-cel) vs SCHOLAR-5 external control in relapsed/refractory follicular lymphoma
por: Ghione, Paola, et al.
Publicado: (2022)

In vivo HSC transduction in rhesus macaques with an HDAd5/3+ vector targeting desmoglein 2 and transiently overexpressing cxcr4
por: Wang, Hongjie, et al.
Publicado: (2022)

Transcutaneous ultrasound-mediated gene delivery into canine livers achieves therapeutic levels of factor VIII expression
por: Manson, Megan A., et al.
Publicado: (2022)

CD14(+)/CD31(+) monocytes expanded by UM171 correct hemophilia A in zebrafish upon lentiviral gene transfer of factor VIII
por: Elnaggar, Muhammad, et al.
Publicado: (2022)

In vivo HSC prime editing rescues sickle cell disease in a mouse model
por: Li, Chang, et al.
Publicado: (2023)

Lipid nanoparticles allow efficient and harmless ex vivo gene editing of human hematopoietic cells
por: Vavassori, Valentina, et al.
Publicado: (2023)

Stable and durable factor IX levels in patients with hemophilia B over 3 years after etranacogene dezaparvovec gene therapy
por: von Drygalski, Annette, et al.
Publicado: (2022)

Identification of evolutionary mechanisms of myelomatous effusion by single-cell RNA sequencing
por: Sun, Zhengxu, et al.
Publicado: (2023)

A comprehensive landscape of transcription profiles and data resources for human leukemia
por: Luo, Mei, et al.
Publicado: (2023)

Intrathymic AAV delivery results in therapeutic site-specific integration at TCR loci in mice
por: Calabria, Andrea, et al.
Publicado: (2023)

CAR NK-92 cell–mediated depletion of residual TCR(+) cells for ultrapure allogeneic TCR-deleted CAR T-cell products
por: Kath, Jonas, et al.
Publicado: (2023)

Base-editing-mediated dissection of a γ-globin cis-regulatory element for the therapeutic reactivation of fetal hemoglobin expression
por: Antoniou, Panagiotis, et al.
Publicado: (2022)

Base and Prime Editing Technologies for Blood Disorders
por: Antoniou, Panagiotis, et al.
Publicado: (2021)

Novel genome-editing-based approaches to treat motor neuron diseases: Promises and challenges
por: Miccio, Annarita, et al.
Publicado: (2022)

Epigenetic Regulation of β-Globin Genes and the Potential to Treat Hemoglobinopathies through Epigenome Editing
por: Fontana, Letizia, et al.
Publicado: (2023)

Cellular and gene therapy
por: Padua, Rose Ann
Publicado: (2019)

CRISPR-mediated gene modification of hematopoietic stem cells with beta-thalassemia IVS-1-110 mutation
por: Gabr, Hala, et al.
Publicado: (2020)

Simplified adenine base editors improve adenine base editing efficiency in rice
por: Hua, Kai, et al.
Publicado: (2019)

Improving cytidine and adenine base editors by expression optimization and ancestral reconstruction
por: Koblan, Luke W., et al.
Publicado: (2018)

Role of Hydrogen Bonding in the Formation of Adenine Chains on Cu(110) Surfaces
por: Cheng, Lanxia
Publicado: (2016)

Relative and Absolute Quantification of Aberrant and Normal Splice Variants in HBB(IVSI−110 (G > A)) β-Thalassemia
por: Patsali, Petros, et al.
Publicado: (2020)

Targeting fidelity of adenine and cytosine base editors in mouse embryos
por: Lee, Hye Kyung, et al.
Publicado: (2018)

Examination of the Cell Cycle Dependence of Cytosine and Adenine Base Editors
por: Burnett, Cameron A., et al.
Publicado: (2022)

THER-05. GENETICALLY STABLE POLIOVIRUS VECTOR CARRYING H3.3K27M ANTIGEN FOR TREATMENT OF DIFFUSE MIDLINE GLIOMA BY INTRAMUSCULAR INJECTION
por: Mosaheb, Mubeen, et al.
Publicado: (2020)

THER-04. IS THERE A ROLE FOR CANNABIDIOL IN THE TREATMENT OF CHILDHOOD BRAIN TUMOURS?
por: Lockwood, George, et al.
Publicado: (2020)

THER-09. ONCOLYTIC ADENOVIRUS, DNX-2401, FOR NAIVE DIFFUSE INTRINSIC PONTINE GLIOMAS: A PHASE I CLINICAL TRIAL
por: Iñigo-Marco, Ignacio, et al.
Publicado: (2020)

THER-06. THERAPEUTIC EFFICACY OF RRV-MEDIATED PRODRUG ACTIVATOR GENE THERAPY IN CLINICAL TRIALS OF RECURRENT HIGH-GRADE GLIOMA AND IN MURINE ORTHOTOPIC MODELS OF INTRACEREBRAL GLIOMA AND INTRACEREBELLAR MEDULLOBLASTOMA
por: Richardson, Angela, et al.
Publicado: (2020)

THER-02. EVALUATION OF THE ONCOLYTIC VIRUS DELTA24-RGD AS AN ANTI-TUMOR AGENT IN PRECLINICAL MODELS OF LOCALIZED AND DISSEMINATED AT/RT
por: Garcia-Moure, Marc, et al.
Publicado: (2020)

THER-07. INHIBITION OF THE RAS SIGNALING ENHANCES VIRAL ONCOLYSIS IN MALIGNANT GLIOMAS
por: Arakawa, Yoshiki, et al.
Publicado: (2020)

THER-08. SGT53 – A NOVEL p53 NANOMEDICINE INDUCES SIGNIFICANT RESPONSES IN CHILDREN WITH RECURRENT MEDULLOBLASTOMA AND CHOROID PLEXUS CARCINOMA: A REPORT OF TWO CASES
por: Hwang, Eugene, et al.
Publicado: (2020)

THER-03. IN VITRO EVALUATION OF THE EFFECT OF CANNABIDIOL ON PAEDIATRIC BRAIN TUMOUR CELL LINES USING A PULSED TREATMENT REGIME
por: Faulkes, Sophie, et al.
Publicado: (2020)

THER-01. AWAKING THE IMMUNE SYSTEM WITH AN IMMUNO-ONCOLYTIC VIRUS AS A THERAPEUTIC STRATEGY FOR DIPGs
por: Laspidea, Virginia, et al.
Publicado: (2020)

THER-01. Precision brain tumor therapy by AAV-mediated oncogene editing
por: von Soosten, Laura, et al.
Publicado: (2022)

THER-02. Pediatric brain tumor cultures reveal differential susceptibility to four oncolytic viruses
por: Vazaios, Konstantinos, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_77tesuu0jgq3uke3lgn21d3j0u